In addition, Arsb participated in the mechanism regulating cardiac hypertrophy and apoptosis by modulating the STAT3 pathway, which may be a new pathway activated by an Arsb deficiency or a new therapeutic target for MPS VI in cardiomyocytes. The gene discussed is STAT3; the disease is hypertrophy.